ArticleArchives of endocrinology and metabolism2021

Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density.

Frederico Arthur Pereira Nunes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.